You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
19 March 2024
ActiTrexx treats first patient with novel regulatory T cell therapy against Graft-versus-Host Disease
2 March 2021
Newly founded biotech company ActiTrexx receives funding of € 3.5 million to develop cell therapy against transplant rejection